PERINDOPRIL ERBUMINE

PERINDOPRIL ERBUMINE was reported 5663 times

PERINDOPRIL ERBUMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VERTEBRAL END PLATE INFLAMMATION 6 0.3000
1 PORTAL VEIN FLOW DECREASED 7 0.1707
2 BLADDER TRANSITIONAL CELL CARCINOMA STAGE II 4 0.0870
3 VENTRICULAR HYPERKINESIA 7 0.0787
4 EJECTION FRACTION 35 0.0602
5 CARDIOACTIVE DRUG LEVEL DECREASED 9 0.0526
6 SENSITISATION 39 0.0514
7 ANOTIA 4 0.0465
8 LEFT VENTRICULAR ENLARGEMENT 11 0.0431
9 SPERMATOZOA PROGRESSIVE MOTILITY DECREASED 7 0.0414
10 RHEUMATOID FACTOR NEGATIVE 7 0.0400
11 PELVIC PROLAPSE 7 0.0389
12 RIGHT ATRIAL ENLARGEMENT 7 0.0354
13 HYPOCHROMASIA 7 0.0348
14 VENOUS PRESSURE JUGULAR INCREASED 12 0.0331
15 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 16 0.0306
16 PLEURAL ADHESION 5 0.0250
17 MITRAL VALVE THICKENING 7 0.0235
18 POLYCYSTIC OVARIAN SYNDROME 9 0.0234
19 POLYCYSTIC OVARIES 36 0.0232
20 COLON CANCER STAGE II 5 0.0226
21 OBSTRUCTIVE SLEEP APNOEA SYNDROME 33 0.0226
22 EJECTION FRACTION ABNORMAL 27 0.0220
23 BODY MASS INDEX DECREASED 10 0.0216
24 NEPHRECTOMY 28 0.0188
25 IMMUNOGLOBULIN G4 RELATED DISEASE 6 0.0188
26 CORNEAL INFECTION 4 0.0184
27 HYPERPARATHYROIDISM PRIMARY 6 0.0165
28 PULMONARY CALCIFICATION 6 0.0145
29 BRONCHIAL HYPERREACTIVITY 17 0.0141
30 SYNOVIAL DISORDER 6 0.0132
31 LEFT ATRIAL ENLARGEMENT 7 0.0130
32 OESOPHAGEAL IRRITATION 7 0.0120
33 SKIN OEDEMA 12 0.0120
34 ALLERGIC SINUSITIS 10 0.0117
35 MEAN PLATELET VOLUME INCREASED 7 0.0116
36 CYTOLYTIC HEPATITIS 38 0.0114
37 PULMONARY FUNCTION TEST ABNORMAL 16 0.0103
38 RETROPERITONEAL FIBROSIS 6 0.0103
39 PAROTITIS 11 0.0095
40 GINGIVAL ABSCESS 7 0.0093
41 RHINITIS ALLERGIC 39 0.0088
42 MORBID THOUGHTS 10 0.0085
43 ANAEMIA HAEMOLYTIC AUTOIMMUNE 7 0.0085
44 SINOATRIAL BLOCK 5 0.0084
45 LOSS OF EMPLOYMENT 25 0.0083
46 CARDIAC ANEURYSM 8 0.0081
47 DISCHARGE 11 0.0079
48 PRESSURE OF SPEECH 5 0.0077
49 CONSCIOUSNESS FLUCTUATING 8 0.0077
50 PROTHROMBIN LEVEL DECREASED 7 0.0074
51 VACCINATION COMPLICATION 6 0.0073
52 ALVEOLITIS 10 0.0071
53 PARATHYROID TUMOUR BENIGN 5 0.0067
54 ADRENAL ADENOMA 4 0.0067
55 LIVEDO RETICULARIS 14 0.0067
56 ANXIETY DISORDER 22 0.0066
57 ISCHAEMIC CARDIOMYOPATHY 20 0.0065
58 CHONDROCALCINOSIS PYROPHOSPHATE 5 0.0065
59 TELANGIECTASIA 6 0.0062
60 BLOOD PRESSURE DIASTOLIC ABNORMAL 15 0.0059
61 AXONAL NEUROPATHY 5 0.0057
62 OESOPHAGEAL SPASM 10 0.0054
63 SKIN INDURATION 11 0.0053
64 SACROILIITIS 10 0.0053
65 BLOOD CHLORIDE INCREASED 9 0.0052
66 STOMA COMPLICATION 5 0.0049
67 BLOOD PRESSURE DIASTOLIC DECREASED 36 0.0049
68 PHYSICAL ASSAULT 10 0.0048
69 MEAN CELL VOLUME DECREASED 7 0.0045
70 ALLERGIC REACTION TO EXCIPIENT 9 0.0045
71 EYE OEDEMA 11 0.0045
72 VASCULAR PURPURA 6 0.0043
73 HYPERTENSIVE HEART DISEASE 8 0.0043
74 BRAIN STEM HAEMORRHAGE 4 0.0042
75 LABELLED DRUG-DRUG INTERACTION ISSUE 6 0.0041
76 CEREBELLAR SYNDROME 9 0.0041
77 BLOOD AMYLASE INCREASED 7 0.0041
78 RETROPERITONEAL HAEMATOMA 9 0.0041
79 BLOOD PRESSURE SYSTOLIC ABNORMAL 10 0.0040
80 BLOOD PHOSPHORUS INCREASED 11 0.0040
81 ABDOMINAL TENDERNESS 20 0.0040
82 GASTROINTESTINAL WALL THICKENING 6 0.0040
83 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0040
84 CORONARY ARTERY STENOSIS 20 0.0040
85 TROPONIN T INCREASED 5 0.0039
86 ACUTE PULMONARY OEDEMA 22 0.0039
87 DIASTOLIC DYSFUNCTION 12 0.0039
88 LEFT VENTRICULAR DYSFUNCTION 26 0.0039
89 IDIOPATHIC THROMBOCYTOPENIC PURPURA 6 0.0038
90 RENAL FAILURE ACUTE 160 0.0038
91 BREATH SOUNDS ABNORMAL 18 0.0036
92 FAECES PALE 8 0.0036
93 DIABETIC FOOT 11 0.0036
94 CEREBRAL HAEMATOMA 12 0.0036
95 PROTHROMBIN TIME SHORTENED 5 0.0036
96 NEPHROPATHY TOXIC 40 0.0036
97 FOOD AVERSION 6 0.0035
98 LOWER RESPIRATORY TRACT CONGESTION 6 0.0035
99 AORTIC VALVE INCOMPETENCE 15 0.0035
100 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 8 0.0035
101 CHRONIC SPONTANEOUS URTICARIA 4 0.0034
102 BLOOD PRESSURE SYSTOLIC INCREASED 67 0.0034
103 JAUNDICE CHOLESTATIC 12 0.0034
104 CONTRAINDICATION TO MEDICAL TREATMENT 5 0.0033
105 ACUTE CORONARY SYNDROME 27 0.0033
106 CARDIAC MURMUR 28 0.0032
107 LUNG CONSOLIDATION 9 0.0032
108 DRUG TOLERANCE DECREASED 9 0.0032
109 ELECTROCARDIOGRAM T WAVE INVERSION 7 0.0032
110 DERMATOMYOSITIS 8 0.0032
111 VITAMIN B12 DECREASED 9 0.0031
112 NEPHROPATHY 29 0.0031
113 ESCHERICHIA SEPSIS 9 0.0031
114 SLEEP APNOEA SYNDROME 59 0.0031
115 BLOOD PARATHYROID HORMONE INCREASED 9 0.0031
116 BLOOD TEST ABNORMAL 43 0.0031
117 JOINT NOISE 6 0.0031
118 VASOPLEGIA SYNDROME 5 0.0030
119 BLOOD PRESSURE DIASTOLIC INCREASED 14 0.0030
120 FULL BLOOD COUNT ABNORMAL 32 0.0030
121 CREPITATIONS 9 0.0030
122 POST PROCEDURAL HAEMATOMA 5 0.0030
123 BLOOD URIC ACID INCREASED 17 0.0029
124 DYSAESTHESIA 9 0.0029
125 CARPAL TUNNEL SYNDROME 41 0.0029
126 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 19 0.0029
127 NECK MASS 8 0.0028
128 ANAEMIA MACROCYTIC 6 0.0028
129 INTERNATIONAL NORMALISED RATIO INCREASED 80 0.0028
130 OESOPHAGEAL PAIN 11 0.0028
131 METASTATIC NEOPLASM 12 0.0028
132 CARDIOMYOPATHY 41 0.0028
133 COMA SCALE ABNORMAL 8 0.0028
134 ATRIAL FLUTTER 22 0.0028
135 PULSE ABSENT 13 0.0027
136 THROMBOCYTOSIS 10 0.0027
137 BLOOD THYROID STIMULATING HORMONE ABNORMAL 5 0.0027
138 FIBROMYALGIA 65 0.0027
139 BLOOD IRON INCREASED 5 0.0027
140 LYMPHOEDEMA 18 0.0026
141 ESCHERICHIA URINARY TRACT INFECTION 11 0.0026
142 CHONDROPATHY 7 0.0026
143 BLOOD BLISTER 8 0.0026
144 CONCOMITANT DISEASE PROGRESSION 5 0.0026
145 ANURIA 22 0.0026
146 CONTRAINDICATED PRODUCT ADMINISTERED 77 0.0025
147 BLOOD IRON DECREASED 30 0.0025
148 CELL DEATH 5 0.0025
149 ORTHOPNOEA 8 0.0025
150 EOSINOPHILIA 44 0.0025
151 MONOCYTE COUNT INCREASED 9 0.0025
152 HEPATIC STEATOSIS 46 0.0025
153 FACIAL PARALYSIS 21 0.0025
154 ANTINUCLEAR ANTIBODY POSITIVE 8 0.0025
155 HAEMATOLOGICAL INFECTION 6 0.0025
156 INTERNATIONAL NORMALISED RATIO FLUCTUATION 5 0.0024
157 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
158 HYPERNATRAEMIA 12 0.0024
159 MELAENA 53 0.0024
160 SUBILEUS 5 0.0024
161 BLOOD CULTURE POSITIVE 7 0.0023
162 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
163 HYPERKALAEMIA 81 0.0023
164 HEPATITIS TOXIC 6 0.0023
165 HUMERUS FRACTURE 11 0.0023
166 SERUM FERRITIN INCREASED 12 0.0023
167 BONE EROSION 8 0.0023
168 ANOREXIA 29 0.0022
169 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 38 0.0022
170 DRUG MONITORING PROCEDURE NOT PERFORMED 4 0.0022
171 IRON DEFICIENCY 10 0.0022
172 BLOOD PRESSURE FLUCTUATION 53 0.0022
173 CONDUCTION DISORDER 4 0.0022
174 VENTRICULAR FIBRILLATION 24 0.0022
175 LIVER ABSCESS 7 0.0022
176 GASTRITIS EROSIVE 10 0.0021
177 VITILIGO 5 0.0021
178 BUNDLE BRANCH BLOCK LEFT 9 0.0021
179 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
180 THERAPEUTIC AGENT TOXICITY 7 0.0021
181 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
182 FINGER DEFORMITY 10 0.0021
183 LEFT VENTRICULAR FAILURE 7 0.0020
184 HAEMODIALYSIS 17 0.0020
185 MUSCLE HAEMORRHAGE 8 0.0020
186 HYPONATRAEMIA 112 0.0020
187 TOXIC SKIN ERUPTION 20 0.0020
188 DUODENAL ULCER 14 0.0020
189 DYSLIPIDAEMIA 10 0.0020
190 NEUTROPHIL COUNT INCREASED 20 0.0020
191 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 20 0.0019
192 EUGLYCAEMIC DIABETIC KETOACIDOSIS 8 0.0019
193 VENTRICULAR DYSFUNCTION 5 0.0019
194 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
195 LIP SWELLING 64 0.0019
196 YELLOW SKIN 9 0.0019
197 CUTANEOUS VASCULITIS 7 0.0019
198 VENTRICULAR ARRHYTHMIA 7 0.0019
199 BLOOD UREA INCREASED 32 0.0019
200 DILATATION VENTRICULAR 4 0.0019
201 JOINT EFFUSION 13 0.0019
202 NASAL DISORDER 5 0.0019
203 SEROTONIN SYNDROME 36 0.0019
204 WHITE BLOOD CELL DISORDER 5 0.0019
205 CARDIAC FAILURE 150 0.0019
206 MULTIPLE DRUG OVERDOSE INTENTIONAL 6 0.0019
207 MITRAL VALVE INCOMPETENCE 21 0.0019
208 HEART RATE DECREASED 65 0.0018
209 DEPRESSED LEVEL OF CONSCIOUSNESS 73 0.0018
210 TONGUE OEDEMA 7 0.0018
211 MUCOUS STOOLS 9 0.0018
212 GASTROINTESTINAL SOUNDS ABNORMAL 9 0.0018
213 PURPURA 16 0.0018
214 ELECTROCARDIOGRAM QT PROLONGED 65 0.0018
215 OBSTRUCTIVE AIRWAYS DISORDER 20 0.0018
216 TONGUE ULCERATION 6 0.0018
217 ANGIOEDEMA 78 0.0018
218 BLOOD PRESSURE SYSTOLIC DECREASED 8 0.0018
219 PANCREATIC CARCINOMA METASTATIC 5 0.0018
220 BRONCHOPNEUMONIA 6 0.0018
221 NEPHROTIC SYNDROME 12 0.0017
222 WOUND COMPLICATION 6 0.0017
223 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
224 BODY TEMPERATURE DECREASED 17 0.0017
225 DYSPNOEA AT REST 5 0.0017
226 HYPOTHYROIDISM 55 0.0017
227 SHOCK HAEMORRHAGIC 14 0.0017
228 THERAPEUTIC REACTION TIME DECREASED 5 0.0017
229 HYPOVOLAEMIA 10 0.0017
230 SPINAL STENOSIS 7 0.0017
231 ANGINA UNSTABLE 11 0.0017
232 ATRIOVENTRICULAR BLOCK 13 0.0017
233 NEUTROPENIC SEPSIS 12 0.0017
234 RHABDOMYOLYSIS 70 0.0017
235 SELF-INJURIOUS IDEATION 7 0.0017
236 ORTHOSTATIC HYPOTENSION 29 0.0017
237 NORMOCHROMIC NORMOCYTIC ANAEMIA 5 0.0017
238 HEPATITIS CHOLESTATIC 10 0.0017
239 TOOTH FRACTURE 18 0.0016
240 HYPERVOLAEMIA 8 0.0016
241 DRUG TOXICITY 22 0.0016
242 MULTIPLE DRUG OVERDOSE 8 0.0016
243 HYDRONEPHROSIS 12 0.0016
244 DRUG INTERACTION 254 0.0016
245 KLEBSIELLA INFECTION 8 0.0016
246 HYPOMAGNESAEMIA 22 0.0016
247 TROPONIN INCREASED 12 0.0016
248 VENTRICULAR TACHYCARDIA 26 0.0016
249 HYPERTHERMIA 12 0.0016
250 ANGINA PECTORIS 45 0.0016
251 CLAVICLE FRACTURE 6 0.0016
252 FEMORAL NECK FRACTURE 8 0.0016
253 LIVER FUNCTION TEST ABNORMAL 45 0.0015
254 POOR VENOUS ACCESS 16 0.0015
255 UPPER GASTROINTESTINAL HAEMORRHAGE 26 0.0015
256 SKIN PLAQUE 13 0.0015
257 HEPATITIS ACUTE 10 0.0015
258 CARDIOGENIC SHOCK 22 0.0015
259 WOUND SECRETION 6 0.0015
260 PSEUDOMONAS INFECTION 13 0.0015
261 BRADYCARDIA 80 0.0015
262 CEREBRAL ATROPHY 6 0.0015
263 METABOLIC ACIDOSIS 48 0.0015
264 ARTHROPOD BITE 11 0.0015
265 VITAMIN B12 DEFICIENCY 6 0.0015
266 POST PROCEDURAL INFECTION 12 0.0015
267 SARCOIDOSIS 7 0.0015
268 PIGMENTATION DISORDER 9 0.0015
269 GOUT 26 0.0014
270 VIITH NERVE PARALYSIS 5 0.0014
271 EOSINOPHIL COUNT INCREASED 12 0.0014
272 OROPHARYNGEAL DISCOMFORT 13 0.0014
273 AORTIC STENOSIS 5 0.0014
274 DISSOCIATION 11 0.0014
275 MULTIPLE INJURIES 9 0.0014
276 HAEMATOMA 37 0.0014
277 RENAL TUBULAR NECROSIS 14 0.0014
278 RIGHT VENTRICULAR FAILURE 10 0.0014
279 HEPATOMEGALY 14 0.0014
280 ERYTHEMA NODOSUM 5 0.0014
281 LACTIC ACIDOSIS 46 0.0014
282 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
283 CARDIAC FAILURE CHRONIC 6 0.0014
284 MYOCARDIAL ISCHAEMIA 16 0.0014
285 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
286 NEUROLOGICAL SYMPTOM 8 0.0014
287 HYPERTONIA 8 0.0014
288 OSTEOARTHRITIS 59 0.0014
289 LOWER RESPIRATORY TRACT INFECTION 63 0.0014
290 CARDIOMEGALY 17 0.0014
291 MENTAL DISORDER 60 0.0014
292 RALES 8 0.0014
293 HYPOCALCAEMIA 26 0.0014
294 FACE OEDEMA 23 0.0014
295 ALCOHOL USE 5 0.0014
296 CIRCULATORY COLLAPSE 23 0.0013
297 BLOOD PRESSURE INADEQUATELY CONTROLLED 8 0.0013
298 UVEITIS 18 0.0013
299 SUDDEN DEATH 14 0.0013
300 HEMIPLEGIA 11 0.0013
301 CATHETER SITE INFECTION 5 0.0013
302 CRANIOCEREBRAL INJURY 4 0.0013
303 RENAL DISORDER 61 0.0013
304 DIPLOPIA 34 0.0013
305 BUNDLE BRANCH BLOCK RIGHT 6 0.0013
306 LIPASE INCREASED 10 0.0013
307 GINGIVAL DISORDER 5 0.0013
308 HYPOKALAEMIA 60 0.0013
309 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
310 C-REACTIVE PROTEIN INCREASED 47 0.0013
311 AGRANULOCYTOSIS 24 0.0013
312 FAECALOMA 7 0.0013
313 GASTRIC ULCER 24 0.0013
314 TRICUSPID VALVE INCOMPETENCE 10 0.0013
315 FAECAL INCONTINENCE 6 0.0012
316 ORGAN FAILURE 5 0.0012
317 ATRIAL FIBRILLATION 120 0.0012
318 PERIPHERAL ISCHAEMIA 5 0.0012
319 HYPERTENSION 258 0.0012
320 PROTEIN URINE PRESENT 6 0.0012
321 SKIN ULCER 31 0.0012
322 DERMATITIS EXFOLIATIVE 6 0.0012
323 HYPOGLYCAEMIA 58 0.0012
324 SKIN LACERATION 13 0.0012
325 OESOPHAGITIS 13 0.0012
326 HAEMODYNAMIC INSTABILITY 9 0.0012
327 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
328 CORONARY ARTERY OCCLUSION 16 0.0012
329 APHTHOUS ULCER 9 0.0012
330 TRANSIENT ISCHAEMIC ATTACK 39 0.0012
331 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
332 TENSION 7 0.0011
333 CHOLESTASIS 22 0.0011
334 URINE OUTPUT DECREASED 10 0.0011
335 MELANOCYTIC NAEVUS 5 0.0011
336 SINUS TACHYCARDIA 16 0.0011
337 HEMIPARESIS 19 0.0011
338 SUBDURAL HAEMATOMA 16 0.0011
339 BLOOD CREATINE PHOSPHOKINASE INCREASED 32 0.0011
340 SUSPECTED OFF LABEL USE 5 0.0011
341 OEDEMA 60 0.0011
342 GASTROENTERITIS 16 0.0011
343 RECTAL HAEMORRHAGE 47 0.0011
344 MOUTH ULCERATION 23 0.0011
345 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
346 IRON DEFICIENCY ANAEMIA 10 0.0011
347 SYNOVIAL CYST 5 0.0011
348 EAR PAIN 21 0.0011
349 TRANSAMINASES INCREASED 24 0.0011
350 MASS 15 0.0011
351 MULTIPLE MYELOMA 5 0.0011
352 BLOOD CREATININE INCREASED 70 0.0011
353 ANGIOPATHY 6 0.0011
354 CARDIAC TAMPONADE 5 0.0011
355 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
356 RENAL FAILURE 139 0.0010
357 SWELLING FACE 68 0.0010
358 HYPERCHOLESTEROLAEMIA 10 0.0010
359 DRUG INTOLERANCE 100 0.0010
360 SKIN WARM 6 0.0010
361 SYNCOPE 103 0.0010
362 HYPOALBUMINAEMIA 8 0.0010
363 HEPATIC FAILURE 31 0.0010
364 THERAPEUTIC PRODUCT EFFECT DECREASED 46 0.0010
365 CARDIOPULMONARY FAILURE 4 0.0010
366 LETHARGY 59 0.0010
367 URINARY RETENTION 34 0.0010
368 HEART RATE IRREGULAR 23 0.0010
369 ACUTE MYOCARDIAL INFARCTION 30 0.0010
370 STAPHYLOCOCCAL SEPSIS 5 0.0010
371 DYSPNOEA EXERTIONAL 38 0.0010
372 ISCHAEMIC STROKE 18 0.0010
373 BLOOD ALBUMIN DECREASED 8 0.0010
374 ERYSIPELAS 5 0.0010
375 RED BLOOD CELL SEDIMENTATION RATE INCREASED 11 0.0010
376 SWOLLEN TONGUE 31 0.0010
377 LIVER DISORDER 44 0.0010
378 PULMONARY FIBROSIS 19 0.0010
379 HYPERTENSIVE CRISIS 11 0.0010
380 HYPOTHERMIA 10 0.0010
381 PULMONARY CONGESTION 13 0.0010
382 BLOOD POTASSIUM INCREASED 16 0.0010
383 PHLEBITIS 5 0.0010
384 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
385 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 5 0.0010
386 CARDIAC DISORDER 91 0.0010
387 OEDEMA PERIPHERAL 118 0.0010
388 INFUSION SITE EXTRAVASATION 6 0.0010
389 BLOOD PRESSURE DECREASED 64 0.0010
390 RASH PUSTULAR 7 0.0010
391 CONGESTIVE CARDIOMYOPATHY 4 0.0010
392 TENDERNESS 10 0.0010
393 PETECHIAE 10 0.0010
394 HYPOTENSION 188 0.0009
395 RESTLESS LEGS SYNDROME 17 0.0009
396 HAEMATURIA 32 0.0009
397 ANAL FISSURE 5 0.0009
398 HAEMOPTYSIS 26 0.0009
399 INTESTINAL RESECTION 5 0.0009
400 GINGIVITIS 5 0.0009
401 MULTI-ORGAN FAILURE 16 0.0009
402 CHEILITIS 5 0.0009
403 DRUG SPECIFIC ANTIBODY PRESENT 6 0.0009
404 SHOCK 21 0.0009
405 CYSTITIS 29 0.0009
406 IMMUNE SYSTEM DISORDER 12 0.0009
407 RENAL FAILURE CHRONIC 7 0.0009
408 DRUG LEVEL BELOW THERAPEUTIC 5 0.0009
409 LYMPHOCYTE COUNT DECREASED 16 0.0009
410 BLOOD CREATINE INCREASED 4 0.0009
411 FOOT DEFORMITY 10 0.0009
412 BLOOD SODIUM DECREASED 17 0.0009
413 INTENTIONAL PRODUCT USE ISSUE 79 0.0009
414 RESPIRATORY RATE INCREASED 8 0.0009
415 CARDIAC FAILURE ACUTE 6 0.0009
416 HAEMORRHAGIC STROKE 7 0.0009
417 GALLBLADDER DISORDER 16 0.0009
418 RENAL IMPAIRMENT 75 0.0009
419 TOOTH EXTRACTION 11 0.0009
420 ABNORMAL LOSS OF WEIGHT 6 0.0009
421 WHEEZING 52 0.0009
422 FALL 291 0.0009
423 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
424 ONYCHOCLASIS 6 0.0009
425 RESPIRATION ABNORMAL 6 0.0009
426 EXERCISE TOLERANCE DECREASED 5 0.0009
427 DIVERTICULITIS 24 0.0009
428 BLOOD PRESSURE INCREASED 132 0.0009
429 HAEMOGLOBIN DECREASED 88 0.0009
430 JAUNDICE 23 0.0009
431 RASH MACULO-PAPULAR 19 0.0009
432 CHOLELITHIASIS 28 0.0009
433 LYMPHOPENIA 12 0.0008
434 PAIN IN JAW 24 0.0008
435 DRUG ERUPTION 15 0.0008
436 PANCREATITIS ACUTE 19 0.0008
437 METASTASIS 6 0.0008
438 TENDONITIS 13 0.0008
439 SKIN LESION 23 0.0008
440 POOR QUALITY SLEEP 18 0.0008
441 ALANINE AMINOTRANSFERASE INCREASED 51 0.0008
442 HEPATITIS B 5 0.0008
443 CORONARY ARTERY DISEASE 25 0.0008
444 CLOSTRIDIUM DIFFICILE INFECTION 18 0.0008
445 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 39 0.0008
446 MYOPATHY 7 0.0008
447 ACUTE KIDNEY INJURY 124 0.0008
448 ABNORMAL WEIGHT GAIN 10 0.0008
449 PALLOR 22 0.0008
450 CHOLANGITIS 5 0.0008
451 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 57 0.0008
452 EATING DISORDER 17 0.0008
453 EYE INFECTION 9 0.0008
454 HYPERGLYCAEMIA 29 0.0008
455 JOINT INJURY 17 0.0008
456 LUNG DISORDER 39 0.0008
457 PEMPHIGOID 6 0.0008
458 DERMATITIS ALLERGIC 10 0.0008
459 IMMUNOSUPPRESSION 7 0.0008
460 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
461 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
462 DEPRESSED MOOD 41 0.0008
463 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
464 HIATUS HERNIA 10 0.0008
465 ASTHMA 87 0.0008
466 BASAL CELL CARCINOMA 12 0.0008
467 PULMONARY HYPERTENSION 16 0.0008
468 OXYGEN SATURATION DECREASED 43 0.0008
469 BLOOD POTASSIUM DECREASED 23 0.0008
470 BLOOD LACTIC ACID INCREASED 4 0.0008
471 GRAND MAL CONVULSION 7 0.0008
472 BRONCHITIS 56 0.0008
473 BURNING SENSATION 53 0.0008
474 THERAPEUTIC RESPONSE SHORTENED 25 0.0008
475 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 39 0.0007
476 ARTERIOSCLEROSIS 7 0.0007
477 SQUAMOUS CELL CARCINOMA 7 0.0007
478 FRUSTRATION TOLERANCE DECREASED 6 0.0007
479 DECREASED ACTIVITY 8 0.0007
480 SEPSIS 82 0.0007
481 ABNORMAL FAECES 6 0.0007
482 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
483 MALAISE 320 0.0007
484 ECCHYMOSIS 5 0.0007
485 DEHYDRATION 97 0.0007
486 GASTROINTESTINAL PAIN 8 0.0007
487 EYE SWELLING 27 0.0007
488 BLOOD ALKALINE PHOSPHATASE INCREASED 18 0.0007
489 INTERSTITIAL LUNG DISEASE 35 0.0007
490 STEVENS-JOHNSON SYNDROME 16 0.0007
491 PARKINSONISM 7 0.0007
492 ANKLE FRACTURE 11 0.0007
493 HYPOXIA 25 0.0007
494 CARDIAC FAILURE CONGESTIVE 57 0.0007
495 LUNG INFECTION 11 0.0007
496 EJECTION FRACTION DECREASED 11 0.0007
497 HAEMATOCRIT DECREASED 14 0.0007
498 DIVERTICULUM 5 0.0007
499 HEPATITIS 18 0.0007
500 NECK PAIN 39 0.0007
501 ASPARTATE AMINOTRANSFERASE INCREASED 37 0.0007
502 GASTROOESOPHAGEAL REFLUX DISEASE 56 0.0007
503 APHASIA 21 0.0007
504 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
505 CONFUSIONAL STATE 112 0.0007
506 COMA 33 0.0007
507 METASTASES TO LUNG 8 0.0007
508 VIRAL INFECTION 23 0.0007
509 PLATELET COUNT INCREASED 9 0.0007
510 HEPATIC ENZYME INCREASED 47 0.0007
511 HAEMATOCHEZIA 38 0.0007
512 FAECES SOFT 5 0.0007
513 ANKYLOSING SPONDYLITIS 9 0.0007
514 TOOTH INFECTION 9 0.0007
515 DIABETES MELLITUS 52 0.0007
516 MOUTH HAEMORRHAGE 5 0.0007
517 PANCREATITIS 36 0.0007
518 CHEST PAIN 126 0.0007
519 VENTRICULAR EXTRASYSTOLES 7 0.0007
520 HAEMATEMESIS 17 0.0007
521 COUGH 188 0.0007
522 HEPATIC FUNCTION ABNORMAL 25 0.0007
523 DRUG LEVEL INCREASED 11 0.0007
524 INCONTINENCE 7 0.0007
525 TENDON PAIN 5 0.0007
526 RENAL PAIN 7 0.0007
527 BALANCE DISORDER 57 0.0007
528 AORTIC ANEURYSM 5 0.0007
529 ACIDOSIS 5 0.0007
530 TYPE 2 DIABETES MELLITUS 22 0.0007
531 HALLUCINATION 49 0.0006
532 TENDON RUPTURE 8 0.0006
533 HYPERCALCAEMIA 8 0.0006
534 DYSPNOEA 366 0.0006
535 JOINT SWELLING 78 0.0006
536 CYST 8 0.0006
537 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
538 ERYTHEMA MULTIFORME 6 0.0006
539 ACUTE MYELOID LEUKAEMIA 10 0.0006
540 MUSCULOSKELETAL STIFFNESS 56 0.0006
541 HEPATIC CIRRHOSIS 12 0.0006
542 BRAIN FOG 10 0.0006
543 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
544 BODY TEMPERATURE INCREASED 13 0.0006
545 STAPHYLOCOCCAL INFECTION 21 0.0006
546 MYOCARDIAL INFARCTION 111 0.0006
547 DELIRIUM 22 0.0006
548 SPINAL DISORDER 6 0.0006
549 SUICIDAL IDEATION 58 0.0006
550 BLOOD LACTATE DEHYDROGENASE INCREASED 10 0.0006
551 FURUNCLE 5 0.0006
552 ECZEMA 33 0.0006
553 RED BLOOD CELL COUNT DECREASED 18 0.0006
554 RENAL CYST 5 0.0006
555 BLOOD BILIRUBIN INCREASED 17 0.0006
556 HEART RATE INCREASED 62 0.0006
557 PLEURAL EFFUSION 38 0.0006
558 BLOOD DISORDER 5 0.0006
559 ANAEMIA 119 0.0006
560 C-REACTIVE PROTEIN ABNORMAL 4 0.0006
561 MIOSIS 5 0.0006
562 ROTATOR CUFF SYNDROME 8 0.0006
563 BLOOD TRIGLYCERIDES INCREASED 11 0.0006
564 HYPERTHYROIDISM 9 0.0006
565 LOCALISED INFECTION 15 0.0006
566 PRESCRIBED OVERDOSE 12 0.0006
567 RHINITIS 5 0.0006
568 ABDOMINAL PAIN 144 0.0006
569 DYSTONIA 12 0.0006
570 MUSCULAR WEAKNESS 70 0.0006
571 HALLUCINATION, VISUAL 13 0.0006
572 POLYURIA 5 0.0006
573 GASTRITIS 16 0.0006
574 CARDIAC ARREST 50 0.0006
575 SPINAL COMPRESSION FRACTURE 5 0.0006
576 MUSCLE INJURY 5 0.0006
577 ABDOMINAL DISCOMFORT 101 0.0006
578 HAEMORRHAGE INTRACRANIAL 9 0.0006
579 VASCULITIS 7 0.0006
580 HEAD INJURY 19 0.0006
581 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
582 EYE HAEMORRHAGE 8 0.0006
583 MALIGNANT MELANOMA 8 0.0006
584 COLITIS ISCHAEMIC 4 0.0006
585 THROMBOCYTOPENIA 66 0.0006
586 ATAXIA 7 0.0006
587 GENERAL PHYSICAL HEALTH DETERIORATION 68 0.0006
588 CHOLECYSTITIS 7 0.0006
589 CEREBRAL HAEMORRHAGE 21 0.0006
590 ACCIDENT 7 0.0006
591 MUSCLE RIGIDITY 7 0.0006
592 NEEDLE ISSUE 17 0.0006
593 LYMPHOMA 9 0.0006
594 PLATELET COUNT DECREASED 62 0.0006
595 PROSTATIC SPECIFIC ANTIGEN INCREASED 8 0.0006
596 DELUSION 9 0.0006
597 BLOOD MAGNESIUM DECREASED 5 0.0006
598 NOCTURIA 7 0.0006
599 PSYCHOTIC DISORDER 17 0.0006
600 CELLULITIS 29 0.0006
601 POLLAKIURIA 24 0.0006
602 RHEUMATOID ARTHRITIS 65 0.0006
603 ARTHRALGIA 238 0.0006
604 BLOOD CALCIUM INCREASED 5 0.0006
605 TUMOUR LYSIS SYNDROME 5 0.0006
606 NEPHROLITHIASIS 26 0.0006
607 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
608 LYMPHADENOPATHY 20 0.0006
609 PERICARDIAL EFFUSION 13 0.0006
610 FACIAL PAIN 5 0.0006
611 ARTHRITIS 44 0.0006
612 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 4 0.0006
613 GASTROINTESTINAL DISORDER 50 0.0006
614 HAEMOLYTIC ANAEMIA 5 0.0006
615 HAEMARTHROSIS 5 0.0006
616 BLOOD CHOLESTEROL INCREASED 26 0.0006
617 PAIN IN EXTREMITY 164 0.0006
618 SYNOVITIS 10 0.0006
619 THROAT TIGHTNESS 15 0.0006
620 ABDOMINAL PAIN LOWER 14 0.0006
621 BACK DISORDER 9 0.0006
622 MYALGIA 94 0.0006
623 DERMATITIS BULLOUS 4 0.0006
624 MUSCLE ATROPHY 7 0.0006
625 SEPTIC SHOCK 24 0.0006
626 HEPATIC CYTOLYSIS 7 0.0005
627 ARRHYTHMIA 26 0.0005
628 LOSS OF CONSCIOUSNESS 70 0.0005
629 ERECTILE DYSFUNCTION 14 0.0005
630 TINNITUS 25 0.0005
631 PSORIATIC ARTHROPATHY 22 0.0005
632 URINARY INCONTINENCE 16 0.0005
633 TOOTH DISORDER 12 0.0005
634 ABDOMINAL PAIN UPPER 111 0.0005
635 PULMONARY MASS 8 0.0005
636 CONDITION AGGRAVATED 163 0.0005
637 PRESYNCOPE 13 0.0005
638 INTESTINAL PERFORATION 6 0.0005
639 FLANK PAIN 5 0.0005
640 BEDRIDDEN 7 0.0005
641 ABORTION INDUCED 5 0.0005
642 MOVEMENT DISORDER 17 0.0005
643 BONE PAIN 31 0.0005
644 SPUTUM DISCOLOURED 5 0.0005
645 MYOCARDITIS 6 0.0005
646 JOINT RANGE OF MOTION DECREASED 7 0.0005
647 PNEUMONIA ASPIRATION 13 0.0005
648 AFFECT LABILITY 5 0.0005
649 CEREBROVASCULAR ACCIDENT 88 0.0005
650 ATELECTASIS 5 0.0005
651 MUSCULOSKELETAL CHEST PAIN 8 0.0005
652 ELECTROLYTE IMBALANCE 6 0.0005
653 LOCAL SWELLING 9 0.0005
654 LIMB INJURY 14 0.0005
655 TACHYPNOEA 7 0.0005
656 PULMONARY OEDEMA 23 0.0005
657 CHOKING 10 0.0005
658 SKIN CANCER 11 0.0005
659 ASCITES 15 0.0005
660 PERIPHERAL COLDNESS 7 0.0005
661 RESPIRATORY DISTRESS 14 0.0005
662 DYSPHAGIA 48 0.0005
663 SINUS DISORDER 10 0.0005
664 HYPERHIDROSIS 65 0.0005
665 ARTHROPATHY 28 0.0005
666 COORDINATION ABNORMAL 7 0.0005
667 PERIPHERAL SWELLING 77 0.0005
668 LEUKOCYTOSIS 9 0.0005
669 SKIN REACTION 7 0.0005
670 NIGHT SWEATS 16 0.0005
671 NO THERAPEUTIC RESPONSE 6 0.0005
672 DRUG LEVEL DECREASED 5 0.0005
673 TOOTH ABSCESS 5 0.0005
674 GASTROINTESTINAL HAEMORRHAGE 41 0.0005
675 EAR INFECTION 13 0.0005
676 GENERALISED OEDEMA 6 0.0005
677 PHARYNGITIS 6 0.0005
678 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
679 PARAESTHESIA 76 0.0005
680 VOMITING 227 0.0005
681 HYPERBILIRUBINAEMIA 5 0.0005
682 DISTURBANCE IN ATTENTION 26 0.0005
683 CYTOMEGALOVIRUS INFECTION 8 0.0005
684 FRACTURE 9 0.0005
685 ANAPHYLACTIC REACTION 26 0.0005
686 RESPIRATORY DISORDER 14 0.0005
687 LIVER FUNCTION TEST INCREASED 10 0.0005
688 URINARY TRACT INFECTION 79 0.0005
689 URTICARIA 77 0.0005
690 PYREXIA 159 0.0005
691 DRUG DISPENSING ERROR 7 0.0005
692 DIABETIC KETOACIDOSIS 11 0.0005
693 JOINT STIFFNESS 12 0.0005
694 WOUND INFECTION 5 0.0005
695 CARDIO-RESPIRATORY ARREST 19 0.0005
696 PALPITATIONS 53 0.0005
697 FLUID RETENTION 23 0.0005
698 DYSARTHRIA 17 0.0005
699 INTESTINAL OBSTRUCTION 17 0.0005
700 ABDOMINAL DISTENSION 47 0.0004
701 CEREBRAL INFARCTION 11 0.0004
702 SKIN DISORDER 15 0.0004
703 AGITATION 33 0.0004
704 CHEST DISCOMFORT 46 0.0004
705 SNEEZING 10 0.0004
706 ABASIA 11 0.0004
707 CYANOSIS 7 0.0004
708 TOOTHACHE 8 0.0004
709 DRY EYE 22 0.0004
710 PNEUMONITIS 12 0.0004
711 HALLUCINATION, AUDITORY 7 0.0004
712 PRODUCTIVE COUGH 21 0.0004
713 RESPIRATORY FAILURE 32 0.0004
714 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 79 0.0004
715 MICTURITION URGENCY 5 0.0004
716 SOMNOLENCE 88 0.0004
717 WEIGHT DECREASED 122 0.0004
718 CATARACT 26 0.0004
719 NEOPLASM MALIGNANT 29 0.0004
720 EYELID OEDEMA 5 0.0004
721 DEMENTIA 12 0.0004
722 BACTERIAL INFECTION 8 0.0004
723 DIARRHOEA HAEMORRHAGIC 4 0.0004
724 ASTHENIA 160 0.0004
725 EPILEPSY 13 0.0004
726 MUSCLE SPASMS 78 0.0004
727 SEASONAL ALLERGY 6 0.0004
728 HEPATOCELLULAR INJURY 6 0.0004
729 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
730 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
731 VISUAL ACUITY REDUCED 14 0.0004
732 DIARRHOEA 272 0.0004
733 TOXICITY TO VARIOUS AGENTS 71 0.0004
734 PROTEINURIA 8 0.0004
735 BRONCHOSPASM 6 0.0004
736 FAECES DISCOLOURED 9 0.0004
737 ANGER 14 0.0004
738 HYPOKINESIA 6 0.0004
739 DIZZINESS 206 0.0004
740 BURSITIS 5 0.0004
741 VERTIGO 25 0.0004
742 HAEMORRHOIDS 8 0.0004
743 HEADACHE 257 0.0004
744 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
745 COGNITIVE DISORDER 19 0.0004
746 HIP FRACTURE 13 0.0004
747 MOBILITY DECREASED 29 0.0004
748 BLADDER DISORDER 4 0.0004
749 ILEUS 5 0.0004
750 RASH PAPULAR 9 0.0004
751 EPISTAXIS 30 0.0004
752 AGEUSIA 10 0.0004
753 RASH MACULAR 14 0.0004
754 LEUKOPENIA 20 0.0004
755 ERYTHEMA 82 0.0004
756 CHROMATURIA 9 0.0004
757 METASTASES TO LIVER 7 0.0004
758 RASH ERYTHEMATOUS 19 0.0004
759 COLD SWEAT 7 0.0004
760 BONE MARROW FAILURE 8 0.0004
761 PANCYTOPENIA 22 0.0004
762 WOUND 11 0.0004
763 PHARYNGEAL OEDEMA 6 0.0004
764 WEIGHT INCREASED 87 0.0004
765 MULTIPLE ORGAN DYSFUNCTION SYNDROME 11 0.0004
766 RHINORRHOEA 25 0.0004
767 PERITONITIS 8 0.0004
768 CHILLS 45 0.0004
769 PRURITUS 147 0.0004
770 HYPERSENSITIVITY 71 0.0004
771 COLITIS ULCERATIVE 17 0.0004
772 THROAT IRRITATION 17 0.0004
773 ABNORMAL BEHAVIOUR 15 0.0004
774 DISORIENTATION 15 0.0004
775 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
776 INFUSION RELATED REACTION 25 0.0004
777 SCIATICA 6 0.0004
778 MIDDLE INSOMNIA 7 0.0004
779 BREAST CANCER METASTATIC 4 0.0004
780 CONVULSION 21 0.0004
781 AKATHISIA 5 0.0004
782 GINGIVAL BLEEDING 5 0.0004
783 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
784 ASPIRATION 4 0.0004
785 RASH 159 0.0004
786 POST PROCEDURAL COMPLICATION 7 0.0004
787 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
788 HAEMORRHAGE 38 0.0004
789 PHOTOSENSITIVITY REACTION 6 0.0004
790 RESPIRATORY ARREST 10 0.0004
791 HERNIA 7 0.0004
792 BACK PAIN 84 0.0004
793 MENTAL STATUS CHANGES 10 0.0004
794 LIMB DISCOMFORT 11 0.0004
795 PNEUMONIA 115 0.0004
796 CARDIOVASCULAR DISORDER 9 0.0004
797 FLATULENCE 20 0.0004
798 DIALYSIS 5 0.0004
799 BONE DENSITY DECREASED 11 0.0004
800 SCAR 6 0.0004
801 VISION BLURRED 48 0.0003
802 PARALYSIS 5 0.0003
803 RASH GENERALISED 9 0.0003
804 PULMONARY EMBOLISM 33 0.0003
805 ADVERSE EVENT 32 0.0003
806 OFF LABEL USE 304 0.0003
807 MUSCLE TWITCHING 8 0.0003
808 PARAESTHESIA ORAL 5 0.0003
809 OROPHARYNGEAL PAIN 32 0.0003
810 NEUTROPENIA 47 0.0003
811 FATIGUE 269 0.0003
812 ANOSMIA 5 0.0003
813 HOT FLUSH 26 0.0003
814 MUSCULOSKELETAL PAIN 18 0.0003
815 NEUTROPHIL COUNT DECREASED 14 0.0003
816 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
817 APATHY 5 0.0003
818 INJECTION SITE WARMTH 7 0.0003
819 RIB FRACTURE 7 0.0003
820 AGGRESSION 17 0.0003
821 DISEASE RECURRENCE 16 0.0003
822 COLON CANCER 5 0.0003
823 IMMUNODEFICIENCY 5 0.0003
824 OSTEONECROSIS 11 0.0003
825 ROAD TRAFFIC ACCIDENT 14 0.0003
826 DRY MOUTH 27 0.0003
827 TREMOR 55 0.0003
828 OSTEOMYELITIS 6 0.0003
829 SWELLING 31 0.0003
830 STOMATITIS 20 0.0003
831 INFLAMMATION 17 0.0003
832 ACCIDENTAL OVERDOSE 12 0.0003
833 HIP ARTHROPLASTY 5 0.0003
834 BLOOD GLUCOSE ABNORMAL 6 0.0003
835 NAUSEA 256 0.0003
836 CONJUNCTIVITIS 6 0.0003
837 GYNAECOMASTIA 10 0.0003
838 FEMUR FRACTURE 10 0.0003
839 GASTRIC DISORDER 11 0.0003
840 NERVOUS SYSTEM DISORDER 10 0.0003
841 SKIN EXFOLIATION 27 0.0003
842 EYE PAIN 18 0.0003
843 PHOTOPHOBIA 6 0.0003
844 GAIT DISTURBANCE 61 0.0003
845 DECREASED APPETITE 74 0.0003
846 BLOOD GLUCOSE INCREASED 60 0.0003
847 FEBRILE NEUTROPENIA 21 0.0003
848 ACNE 24 0.0003
849 IRRITABILITY 19 0.0003
850 INFLUENZA LIKE ILLNESS 26 0.0003
851 ULCER 5 0.0003
852 ABSCESS 5 0.0003
853 HYPOPHAGIA 8 0.0003
854 INFECTION 45 0.0003
855 ANAPHYLACTIC SHOCK 8 0.0003
856 FEELING HOT 19 0.0003
857 DYSSTASIA 9 0.0003
858 RESPIRATORY TRACT INFECTION 8 0.0003
859 DEAFNESS 8 0.0003
860 MUCOSAL INFLAMMATION 8 0.0003
861 TREATMENT FAILURE 25 0.0003
862 UNDERDOSE 22 0.0003
863 DYSURIA 11 0.0003
864 SLEEP DISORDER 21 0.0003
865 RASH PRURITIC 16 0.0003
866 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
867 TACHYCARDIA 26 0.0003
868 MUSCULOSKELETAL DISCOMFORT 5 0.0003
869 COLITIS 11 0.0003
870 PARANOIA 5 0.0003
871 NIGHTMARE 10 0.0003
872 DRUG-INDUCED LIVER INJURY 9 0.0003
873 APHONIA 4 0.0003
874 HOSPITALISATION 44 0.0003
875 DERMATITIS 6 0.0003
876 DYSPEPSIA 28 0.0003
877 SINUSITIS 29 0.0003
878 OVERDOSE 61 0.0003
879 INTENTIONAL DOSE OMISSION 8 0.0003
880 THIRST 5 0.0003
881 DISCOMFORT 17 0.0003
882 AMNESIA 18 0.0003
883 PRODUCT PRESCRIBING ISSUE 6 0.0003
884 EYE DISORDER 9 0.0003
885 MIGRAINE 26 0.0003
886 NASAL CONGESTION 16 0.0003
887 CONSTIPATION 59 0.0003
888 MEDICATION ERROR 15 0.0003
889 MEMORY IMPAIRMENT 37 0.0003
890 LUNG NEOPLASM MALIGNANT 11 0.0003
891 SEDATION 7 0.0003
892 PRODUCT USE ISSUE 50 0.0003
893 BLOOD URINE PRESENT 5 0.0003
894 DEEP VEIN THROMBOSIS 17 0.0003
895 CONTUSION 25 0.0003
896 GLAUCOMA 5 0.0003
897 FREQUENT BOWEL MOVEMENTS 7 0.0003
898 NASOPHARYNGITIS 47 0.0003
899 KIDNEY INFECTION 5 0.0003
900 DISABILITY 5 0.0003
901 PSORIASIS 33 0.0003
902 ILLNESS 26 0.0003
903 PAIN 154 0.0003
904 SPINAL FRACTURE 5 0.0002
905 SPEECH DISORDER 13 0.0002
906 PANIC ATTACK 9 0.0002
907 ILL-DEFINED DISORDER 15 0.0002
908 IMPAIRED HEALING 8 0.0002
909 OSTEONECROSIS OF JAW 6 0.0002
910 ANXIETY 69 0.0002
911 PANCREATIC CARCINOMA 7 0.0002
912 VISUAL IMPAIRMENT 30 0.0002
913 EXTRAPYRAMIDAL DISORDER 6 0.0002
914 DYSPHONIA 14 0.0002
915 FEELING ABNORMAL 57 0.0002
916 TREATMENT NONCOMPLIANCE 13 0.0002
917 KNEE ARTHROPLASTY 5 0.0002
918 INSOMNIA 63 0.0002
919 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
920 RETCHING 5 0.0002
921 COVID-19 41 0.0002
922 LACRIMATION INCREASED 7 0.0002
923 NEOPLASM PROGRESSION 8 0.0002
924 DRUG ADMINISTRATION ERROR 7 0.0002
925 PRODUCT SUBSTITUTION ISSUE 13 0.0002
926 DYSKINESIA 9 0.0002
927 BLINDNESS 9 0.0002
928 INJECTION SITE REACTION 15 0.0002
929 INFLUENZA 24 0.0002
930 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
931 DEPRESSION 48 0.0002
932 DRUG INEFFECTIVE 273 0.0002
933 DRUG WITHDRAWAL SYNDROME 18 0.0002
934 BLADDER CANCER 12 0.0002
935 LIVER INJURY 5 0.0002
936 ENCEPHALOPATHY 5 0.0002
937 INTENTIONAL OVERDOSE 13 0.0002
938 BLOOD PRESSURE ABNORMAL 4 0.0002
939 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
940 CHRONIC KIDNEY DISEASE 15 0.0002
941 SKIN DISCOLOURATION 9 0.0002
942 UNRESPONSIVE TO STIMULI 5 0.0002
943 HERPES ZOSTER 11 0.0002
944 FLUSHING 19 0.0002
945 PROSTATE CANCER 15 0.0002
946 MOOD ALTERED 5 0.0002
947 SUICIDE ATTEMPT 11 0.0002
948 HYPOAESTHESIA 27 0.0002
949 BLISTER 10 0.0002
950 THERAPY CESSATION 9 0.0002
951 OSTEOPOROSIS 7 0.0002
952 PREMATURE BABY 5 0.0002
953 RESTLESSNESS 6 0.0002
954 INCORRECT DOSE ADMINISTERED 37 0.0002
955 DISEASE PROGRESSION 19 0.0002
956 MOOD SWINGS 5 0.0002
957 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
958 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 4 0.0002
959 GAIT INABILITY 5 0.0001
960 THROMBOSIS 12 0.0001
961 THERAPEUTIC RESPONSE DECREASED 9 0.0001
962 SEIZURE 17 0.0001
963 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
964 DRY SKIN 18 0.0001
965 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
966 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
967 DEATH 108 0.0001
968 VAGINAL HAEMORRHAGE 5 0.0001
969 NERVOUSNESS 6 0.0001
970 INJECTION SITE PAIN 35 0.0001
971 CRYING 4 0.0001
972 COMPLETED SUICIDE 9 0.0001
973 DYSGEUSIA 8 0.0001
974 OCULAR HYPERAEMIA 5 0.0001
975 SURGERY 6 0.0001
976 INJECTION SITE BRUISING 8 0.0001
977 ADVERSE DRUG REACTION 9 0.0001
978 ABORTION SPONTANEOUS 4 0.0001
979 NEUROPATHY PERIPHERAL 9 0.0001
980 UNEVALUABLE EVENT 7 0.0001
981 INTENTIONAL PRODUCT MISUSE 8 0.0001
982 INJECTION SITE SWELLING 7 0.0001
983 ALOPECIA 17 0.0001
984 DERMATITIS ATOPIC 4 0.0001
985 BREAST CANCER 7 0.0001
986 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
987 DEVICE ISSUE 6 0.0001
988 INJECTION SITE ERYTHEMA 8 0.0001
989 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
990 PRODUCT DOSE OMISSION ISSUE 18 0.0001
991 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001
992 PRODUCT QUALITY ISSUE 7 0.0001
993 DRUG DEPENDENCE 7 0.0000
994 DRUG DOSE OMISSION 4 0.0000